Apolipoprotein E Facilitates Amyloid-β Oligomer-Induced Tau Phosphorylation. 2020

Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
Department of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.

Hyperphosphorylated tau is one of the key characteristics of Alzheimer's disease (AD), and tau pathology correlates with cognitive impairment in AD better than amyloid-β (Aβ) pathology. Thus, a complete understanding of the relevant factors involved in tau phosphorylation is important for AD treatment. APOEɛ4, the strongest genetic risk factor for AD, was found to be involved in tau pathology in frontotemporal dementia. This result indicated that apolipoprotein E (ApoE) may also participate in tau phosphorylation in AD. In the present study, we injected Aβ oligomer (AβO) into the lateral ventricles of wild-type (WT) mice and apoE-/- mice to test the process of tau phosphorylation in the acute phase. We found that the phosphorylated tau and phosphokinase levels were higher in WT mice than in apoE-/- mice. These phenomena were also confirmed in vitro. ApoE ɛ4-treated apoE-/- neurons exhibited more phosphorylated tau than ApoE ɛ2- and ApoE ɛ3-treated neurons. We also found that AβO induced more serious inflammation in WT mice and in ApoE-positive cultured neurons. Anti-inflammatory treatment reduced the phosphorylated tau level induced by AβOs in ApoE-positive neurons. These results suggest that ApoE may facilitate the phosphorylation of tau induced by AβO via inflammation.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau

Related Publications

Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
February 2011, Proteins,
Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
April 2020, JAMA neurology,
Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
October 1995, Neuroscience letters,
Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
February 2014, Journal of neurochemistry,
Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
January 2015, Journal of Alzheimer's disease : JAD,
Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
July 1998, Neuroscience letters,
Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
May 2017, Journal of agricultural and food chemistry,
Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
March 2018, Neurobiology of disease,
Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
August 2023, Life science alliance,
Ting-Ting Hou, and Yun-Dan Han, and Lin Cong, and Cui-Cui Liu, and Xiao-Yan Liang, and Fu-Zhong Xue, and Yi-Feng Du
May 2017, Science signaling,
Copied contents to your clipboard!